Evaluation of the transforming growth factor β1 codon 25 (Arg → Pro) polymorphism in alcoholic liver disease

Cytokine

Volumn 42, Issue 1, 2008, Pages 18-23

  Österreicher, Christoph H ^a   Halangk, Juliane ^b   Berg, Thomas ^b   Patsenker, Eleonora ^c   Homann, Nils ^d   Hellerbrand, Claus ^e   Seitz, Helmut K ^f   Eurich, Dennis ^g   Stickel, Felix ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF LÜBECK   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcoholic liver disease; Cirrhosis; Genetic risk; Polymorphism; Transforming growth factor 1

Indexed keywords

ALCOHOL; ARGININE; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CODON; CONTROLLED STUDY; DISEASE COURSE; DRINKING BEHAVIOR; FATTY LIVER; FEMALE; GENE FREQUENCY; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALCOHOL DRINKING; ARGININE; CODON; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

HEPATITIS C VIRUS;

EID: 41149164581     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.02.003     Document Type: Article

References (28)

1. Maddrey W.C. Alcohol-induced liver disease. Clin Liver Dis 4 (2000) 115-131 vii
2. Bellentani S., Saccoccio G., Costa G., Tiribelli C., Manenti F., Sodde M., et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41 (1997) 845-850
3. Reed T., Page W.F., Viken R.J., and Christian J.C. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res 20 (1996) 1528-1533
4. Hrubec Z., and Omenn G.S. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 5 (1981) 207-215
5. Stickel F., and Osterreicher C.H. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 41 (2006) 209-224
6. Schuppan D., Ruehl M., Somasundaram R., and Hahn E.G. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21 (2001) 351-372
7. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
8. Bissell D.M., Roulot D., and George J. Transforming growth factor beta and the liver. Hepatology 34 (2001) 859-867
9. Tag C.G., Mengsteab S., Hellerbrand C., Lammert F., Gressner A.M., and Weiskirchen R. Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection. Cytokine 24 (2003) 173-181
10. Gewaltig J., Mangasser-Stephan K., Gartung C., Biesterfeld S., and Gressner A.M. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316 (2002) 83-94
11. Wang H., Mengsteab S., Tag C.G., Gao C.F., Hellerbrand C., Lammert F., et al. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 11 (2005) 1929-1936
12. Osterreicher C.H., Datz C., Stickel F., Hellerbrand C., Penz M., Hofer H., et al. TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. Cytokine 31 (2005) 142-148
13. Bathgate A.J., Pravica V., Perrey C., Hayes P.C., and Hutchinson I.V. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 12 (2000) 1329-1333
14. Oliver J., Agundez J.A., Morales S., Fernandez-Arquero M., Fernandez-Gutierrez B., de la Concha E.G., et al. Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver Int 25 (2005) 935-939
15. Raynard B., Balian A., Fallik D., Capron F., Bedossa P., Chaput J.C., et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35 (2002) 635-638
16. Wiley T.E., McCarthy M., Breidi L., McCarthy M., and Layden T.J. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28 (1998) 805-809
17. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., and Hutchinson I.V. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
18. Bataller R., North K.E., and Brenner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (2003) 493-503
19. Osterreicher C.H., Stickel F., and Brenner D.A. Genomics of liver fibrosis and cirrhosis. Semin Liver Dis 27 (2007) 28-43
20. Powell E.E., Edwards-Smith C.J., Hay J.L., Clouston A.D., Crawford D.H., Shorthouse C., et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31 (2000) 828-833
21. Dixon J.B., Bhathal P.S., Jonsson J.R., Dixon A.F., Powell E.E., and O'Brien P.E. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39 (2003) 967-971
22. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8 (1999) 93-97
23. Thomas D.C., and Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol Biomarkers Prev 11 (2002) 505-512
24. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
25. Lee Y.H., Ji J.D., and Song G.G. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34 (2007) 43-49
26. Paracchini V., Pedotti P., and Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 162 (2005) 101-114
27. Brind A., Fryer A., Hurlstone A., Fisher N., and Pirmohamed M. The role of polymorphism in manganese superoxide dismutase in susceptibility to alcoholic liver disease. Gastroenterology 124 (2003) 2000-2002
28. Stewart S.F., Leathart J.B., Chen Y., Daly A.K., Rolla R., Vay D., et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 36 (2002) 1355-1360